Clinical RoundupFree SANRECO phase II study of divesiran in polycythemia vera meets primary endpoint August 14, 2026Vol.52 No.32
Drugs & TargetsFree FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and dexamethasone for multiple myeloma August 14, 2026Vol.52 No.32
Drugs & TargetsFree FDA advisory committee to vote on GRAIL’s multi-cancer detection test, Galleri August 14, 2026Vol.52 No.32
Drugs & TargetsFree FDA approves companion diagnostic supporting patients with advanced melanoma August 14, 2026Vol.52 No.32
Cancer History ProjectFree Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”Chanock and Brawley reflect on their illustrious mentor July 31, 2026Vol.52 No.30By Sara Willa Ernst
FreeObituary Gary Morrow, a pioneer in supportive oncology, dies of prostate cancer complications at 82 July 24, 2026Vol.52 No.29By Leslie Orr
FreeObituary Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61 July 02, 2026Vol.52 No.26By Paul Goldberg
FreeTrials & Tribulations Is it time to re-assess the practice and practicality of screening colonoscopy?Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives July 02, 2026Vol.52 No.26By Paul J. Limburg
FreeTrials & Tribulations More than 50 million Americans remain unscreened for colon cancerNew guidelines offer another option July 02, 2026Vol.52 No.26By AmirAli Talasaz
FreePodcastThe Directors The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas“Institutions are feeling crunched in so many different directions” June 26, 2026Vol.52 No.25By Paul Goldberg and Claire Marie Porter
